charts

Projects

Diabetes and Obesity Integrative Genomics

Project Description

The past 10 years have led to a variety of measurement tools in molecular biology that are near comprehensive in nature. For example, RNA expression detection microarrays can provide systematic quantitative information on the expression of over 40,000 unique RNAs within cells. Yet microarrays are just one of at least 30 large-scale measurement or experimental modalities available to investigators in molecular biology. We see scientific value in being able to integrate multiple large-scale data sets from all biological modalities to address biomedical questions that could otherwise not be answered. However, we recognize that the full agenda of working out the details for all possible inferential processes between all near-comprehensive modalities is too large.

The goal of this project is to serve as a model automated system for gathering data related to particular experimental characteristic and performing inferential operators on these data. For this application, we are focusing on a pragmatic subset. Specifically, we propose intersecting near comprehensive data sets by phenotype, and intersecting lists of significant and related genes within these data sets in an automated manner. The central hypothesis for this application is that integrating large-scale data sets across measurement modalities is a synergistic process to create new knowledge and testable hypotheses in the areas of diabetes and obesity, and that inferential processes involving intersection across genes can be automated. Funded by the National Library of Medicine (K22 LM008261).

Related Publications Only the 5 most recent displayed

View All Publications

BMIR-2007-1281
Evaluation and Integration of 49 Genome-wide Experiments and the Prediction of Previously Unknown Obesity-related Genes
S. B. English, A. J. Butte
Bioinformatics, Epub. Published in 2007
BMIR-2005-1057
A Computational Model to Define the Molecular Causes of Type 2 Diabetes Mellitus
J. Pollard, A. J. Butte, S. Hoberman, M. Joshi, J. Levy, J. Pappo
Diabetes Technology & Therapeutics, 7, 2, 323-336. Published in 2005
BMIR-2003-1050
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1
M. E. Patti, A. J. Butte, S. Crunkhorn, K. Cusi, R. Berria, S. Kashyap, Y. Miyazaki, I. S. Kohane, M. Costello, R. Saccone, E. J. Landaker, A. B. Goldfine, E. Mun, R. DeFronzo, J. Finlayson, C. Kahn, L. J. Mandarino
Proceedings of the National Academy of Sciences, PNAS, 100, 14, 8466-8471. Published in 2003
BMIR-2003-1047
PGAGENE: integrating quantitative gene-specific results from the NHLBI Programs for Genomic Applications
K. Y. Lee, I. S. Kohane, A. J. Butte
Bioinformatics, 19, 6, 778-779. Published in 2003
BMIR-1994-1055
Tyrosine kinase-deficient mutant human insulin receptors (Met1153-->Ile) overexpressed in transfected rat adipose cells fail to mediate translocation
M. J. Quon, M. Guerre-Millo, M. Zarnowski, A. J. Butte, M. Em, S. W. Cushman, S. I. Taylor
Proceedings of the National Academy of Sciences, 91, 12, 5587-5591. Published in 1994

Stanford School of Medicine